Trial intelligence / Profile preview

Letrozole for increasing endometrial thickness in premenopausal women

IRCT201510244339N12Phase 3Completed

Sponsor
Bushehr University of Medical Sciences
Start
Apr 2012
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 3, open-label, single-arm trial of letrozole in endometrial hyperplasia (EH), sponsored by Bushehr University of Medical Sciences. Started Apr 2012; status: completed.

02

Drugs

letrozole
03

Conditions

endometrial hyperplasia (EH)

Beyond the preview

Go deeper on IRCT201510244339N12.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201510244339N12.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call